Have Questions?

Global Headquarters

Tel: +44 (0)20 7377 0800
Fax: +44 (0)20 7349 5157

North America

Tel: 1-617-573-9450
Fax: 1-617-573-9542


Tel: +81 (0)80-1164-4754

Request a Demo

What our customers are saying

When I think of the future, I think of EvaluatePharma

Senior Director,
Global pharmaceutical company

Press Release

Pharma Sales Forecast to Grow 5% Annually Through to 2020, Industry's R&D Pipeline Valued at $493bn

Annual EvaluatePharma® World Preview Report to Launch at BIO 2015

Download PDF

LONDON, BOSTON, TOKYO (June 11, 2015) — Life science market intelligence firm, Evaluate Ltd, is launching their annual complimentary industry report, “EvaluatePharma World Preview 2015, Outlook to 2020” at the annual BIO International Convention in Philadelphia, June 15-18, 2015 Booth #2111.

The report, which sets the industry standard for consensus forecasts for the life science industry, provides an overview of the sector including key trends, patent expiry impact, top products and companies, R&D spend and consensus forecasts to 2020. Complimentary copies of the executive summary will be available in the Evaluate Booth #2111. Follow @evaluatepharma on twitter or visit www.evaluategroup.com/WP2015 to download the report on release June 16th. For media attending BIO, a press conference will be held on Tuesday June 16th at 9:15 AM in room 202B at the Pennsylvania Convention Center.

The Evaluate team will also be showcasing some key data sets and analyses within the EvaluatePharma service including:

  • FDA Post-marketing Adverse Events Module (FAERS) fully integrated with EvaluatePharma R&D and commercial intelligence
  • USA Sales Volume and Pricing including cost and volume per patient
  • Japan Sales, Volume and Pricing including reference pricing and PMDA Approvals
  • Brazil Sales, Volume and Pricing and ANVISA approvals
  • Premier of Evaluate’s “Market Movers & Shakers” Newsletter
  • Orphan Drugs and Biosimilar Analyses for clear, concise insights

In attendance will be CEO, Alex Karle; Head of Research, Anthony Raeside; R&D Product Manager, Melanie Newman; EP Vantage Editor Lisa Urquhart as well as Evaluate’s USA team including CEO Americas, Debbie Paul, and Vice President, Christine Lindgren. Meetings can be scheduled by going to www.evaluate.com or through the BIO Partnering system, or simply stop by the Evaluate Booth 2111.

About Evaluate Ltd.
Evaluate is the trusted source for life science market intelligence and analysis with exclusive consensus forecasts to 2020. We support life science and healthcare companies, financial institutions, consultancies and service providers in their strategic decision-making. Our services include EvaluatePharma, EvaluateClinical Trials and EvaluateMedTech. Our global team of dedicated healthcare analysts employs rigorous methodologies to deliver strategic commercial analysis. We make our services valuable by combining superior quality content, user-friendly reporting tools and outstanding customer service to solve client problems.

For more information visit: www.evaluategroup.com. On Twitter: @evaluatepharma, @evaluatemedtech, @epclinicaltrial, @epvantage, @evaluateJP.

Back to Press Releases